Drug Type Small molecule drug |
Synonyms Compound 27c |
Target |
Action antagonists, inhibitors |
Mechanism AR antagonists(Androgen Receptor antagonists), AR-v7 inhibitors(androgen receptor splice variant 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H19F4N5O2 |
InChIKeyQMRZVTDYXXBISG-UHFFFAOYSA-N |
CAS Registry2841308-96-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | China | 21 Mar 2024 |